Quick Answer
Progyny, Inc. reported Cash and Equivalents of $112.24 million for fiscal year 2025.
Progyny, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $112.24M | -30.9% |
| 2024 | $162.31M | +66.8% |
| 2023 | $97.30M | -19.0% |
| 2022 | $120.08M | +31.4% |
| 2021 | $91.41M | +30.0% |
| 2020 | $70.31M | -12.5% |
| 2019 | $80.38M | +63192.9% |
| 2018 | $127.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $133.98M | +46.5% | +1.1% |
| June 30, 2025 | $132.51M | +39.5% | +21.3% |
| March 31, 2025 | $109.24M | -5.0% | -32.7% |
| December 31, 2024 | $162.31M | +66.8% | +77.4% |
| September 30, 2024 | $91.48M | -42.1% | -3.7% |
| June 30, 2024 | $94.96M | -44.3% | -17.4% |
| March 31, 2024 | $114.96M | -26.0% | +18.2% |
| December 31, 2023 | $97.30M | -19.0% | -38.4% |
- Progyny, Inc. showed a decrease of -30.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2018–2025 period, Progyny, Inc.’s cash and equivalents has grown by 88276.4% (from $127.0 thousand to $112.24 million).
- The most recent figure is from Progyny, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: